Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction
Markus Wallner, MD, PhD, FESC, FAHA, FHFAExpected time taken: 20 mins
Late Breaking Clinical Trial - Presented at #ESC HF 2022
Sign up to start learning